SAW
GILD icon

Signal Advisors Wealth’s Gilead Sciences GILD Stock Holding History

Signal Advisors Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Buy
2,752
+315
+13% +$41.5K 0.02% 493
2026
Q1 		$340K Buy
+2,437
New +$341K 0.02% 443

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Signal Advisors Wealth's GILD Position: Q2 2026 in Review

Signal Advisors Wealth increased its Gilead Sciences (GILD) stake by 13% in Q2 2026, buying an estimated $41.5K and bringing the position to 2,752 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #493.

Signal Advisors Wealth first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Signal Advisors Wealth held 2,752 shares of Gilead Sciences worth $348K as of Q2 2026.
  • Signal Advisors Wealth bought 315 Gilead Sciences shares in Q2 2026, an estimated $41.5K.
  • Gilead Sciences made up 0.02% of Signal Advisors Wealth's portfolio in Q2 2026, its #493 holding.
  • Signal Advisors Wealth first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.